Inventor
Björn M. Nilsson
Inventor
Uppsala, SE
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides19%
A61KPreparations for medical, dental or toiletry purposes13%
C12NMicroorganisms or enzymes11%
Y02ATechnologies for adaptation to climate change4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
7,820,675'Benzofuran compounds'20107,812,017'4-substituted indole and indoline compounds'20107,534,794'Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases'20097,524,839'Compounds, their use and preparation'20097,247,633'Pyrimidine compounds and their use'20077,244,722'Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones'20077,229,997'Compounds and their use'20077,226,925'Compounds, their use and preparation'20077,087,750'Compounds, their use and preparation'20067,071,180'Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases'20066,818,639'Pharmaceutical combination formulation and method of treatment with the combination'20046,759,401'Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases'20046,756,377'Compounds and their use'20046,740,734'Bacterial receptor structures'20046,617,134'Dimer of molecular variant of apolipoprotein and processes for the production thereof'20036,593,330'Compounds and their use'20036,534,628'Bacterial receptor structures'20036,465,467'Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases'20025,876,968'Dimer of molecular variant of apolipoprotein and processes for the production thereof'19995,831,012'Bacterial receptor structures'19985,683,980'Use of IGF-BP for refolding of IGF'19975,411,732'Preparation of fused proteins, antibodies and processes therefore'19955,156,959'Method to export gene products to the growth medium of gram negative bacteria'19925,143,844'Construction of an IgG binding protein to facilitate downstream processing using protein engineering'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992Patents assigned to KABIGEN AB (2)· patent assignee history
1992–2004Based in Sollentuna, SE· patent location history
1995Based in Foster City, CA, US· patent location history
1997–1999Patents assigned to PHARMACIA & UPJOHN AB (3)· patent assignee history
1997Based in Sollentun, SE· patent location history
2002–2010Patents assigned to BIOVITRUM AB (13)· patent assignee history
2002–2009Based in Uppsala, SE· patent location history
2003Patents assigned to BIOVITRUM (1)· patent assignee history
2007–2010Based in Stockholm, SE· patent location history
2010Patents assigned to BIOVITRUM AB PUBL (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOVITRUM AB | 13 | 2002–2010 |
| PHARMACIA & UPJOHN AB | 3 | 1997–1999 |
| KABIGEN AB | 2 | 1992 |
| BIOVITRUM | 1 | 2003 |
| BIOVITRUM AB PUBL | 1 | 2010 |
Locations
| Location | Patents | Span |
|---|---|---|
| Uppsala, SE | 9 | 2002–2009 |
| Sollentuna, SE | 7 | 1992–2004 |
| Stockholm, SE | 6 | 2007–2010 |
| Sollentun, SE | 1 | 1997 |
| Foster City, California, US | 1 | 1995 |